Guillain Barre Syndrome After COVID-19 Infection
PDF
Cite
Share
Request
Case Report
P: 84-87
November 2021

Guillain Barre Syndrome After COVID-19 Infection

J Eur Med Sci 2021;2(3):84-87
1. Health Science University, Adana City Research and Training Hospital, Department of Emergency Medicine, Adana, Turkey
2. Health Science University, Adana City Research and Training Hospital, Department of Neurology, Adana, Turkey
3. Health Science University, Adana City Research and Training Hospital, Department of Internal Medicine, Adana, Turkey
4. Başkent University, Faculty of Medicine, Department of Emergency Medicine, Adana, Turkey
5. Health Science University, Adana City Research and Training Hospital, Department of Obstetrics and Gynecology, Adana, Turkey
6. Gaziantep 25 Aralık State Hospital, Department of Emergency Medicine, Gaziantep, Turkey
No information available.
No information available
Received Date: 16.09.2021
Accepted Date: 12.12.2021
Online Date: 26.01.2022
PDF
Cite
Share
Request

ABSTRACT

Unexplained pneumonia cases caused by a new coronavirus known as SARS-COV-2, occurred in Wuhan, China since December 2019. Culprit of the worldwide pandemic of the coronavirus disease 2019 (COVID-19), SARS-CoV-2 attach to the angiotensin-converting enzyme 2 receptor, affecting multiple systems such as respiratory, vascular, renal and central nervous system. Most common neurological symp- toms are headache, dizziness, nausea, vomiting, myalgia, anosmia, ageusia and altered consciousness; however, there are reports that suggests an association between Guillain-Barre syndrome (GBS) and COVID-19 infection. Guillain-Barre syndrome (GBS) is an autoimmune polyradiculoneuropathy that characterized with progressive weakness of the limbs and reduction or loss of tendon reflexes. Protein concentrations of cerebrospinal fluid (CSF) are increased and the white cell count is normal. Plasma exchange and intravenous immunoglobulin (IVIG) used in treatment with supportive care and most of patients have full recovery. In this paper we aimed to present a patient with positive real time polymerase chain reaction (RT- PCR) test presenting to the emergency department (ED) with the symptoms of GBS. Keywords: Guillain-barre, COVID-19, COVID